Aspreva Reports First Quarter 2005 Results

Aspreva Pharmaceuticals Corporation, an emerging pharmaceutical company focused on identifying, developing and commercializing new indications for approved drugs and drug candidates for underserved patient populations, today reported business and financial results for the first quarter ended March 31, 2005. Unless otherwise specified, all amounts are in U.S. dollars and are reported under U.S. GAAP.

Canada NewsWire Group (http://www.newswire.ca/en/releases/archive/May2005/12/c8469.html)